Stockscreener 앱 받기
9.31
0.98%
0.09
전일 마감가:
$9.22
열려 있는:
$9.22
하루 거래량:
262.03K
Relative Volume:
0.22
시가총액:
$623.63M
수익:
-
순이익/손실:
$-103.21M
주가수익비율:
-2.0239
EPS:
-4.6001
순현금흐름:
$-26.70M
1주 성능:
+5.68%
1개월 성능:
+11.10%
6개월 성능:
+157.18%
1년 성능:
+32.81%
1일 변동 폭
$9.10
$9.55
1주일 범위
$8.1601
$9.55
52주 변동 폭
$2.65
$11.14
Engene Holdings Inc Stock (ENGN) Company Profile
명칭
Engene Holdings Inc
전화
(514) 332-4888
주소
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
ENGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
9.31 | 617.60M | 0 | -103.21M | -26.70M | -4.6001 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-11 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | 개시 | Piper Sandler | Overweight |
| 2025-02-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-12-23 | 개시 | H.C. Wainwright | Buy |
| 2024-11-27 | 개시 | Raymond James | Outperform |
| 2024-11-18 | 개시 | JMP Securities | Mkt Outperform |
| 2024-08-28 | 개시 | Oppenheimer | Outperform |
| 2024-04-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-15 | 개시 | Guggenheim | Buy |
| 2024-03-28 | 개시 | UBS | Buy |
| 2024-03-08 | 개시 | Morgan Stanley | Overweight |
| 2024-02-20 | 개시 | Leerink Partners | Outperform |
모두보기
Engene Holdings Inc 주식(ENGN)의 최신 뉴스
Aug Summary: Will PCRX announce a stock splitAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Portfolio Update: Can enGene Holdings Inc benefit from deglobalizationJuly 2025 PostEarnings & Risk Managed Trade Strategies - baoquankhu1.vn
AI Stocks: What drives enGene Holdings Inc Equity Warrants stock price2025 Historical Comparison & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Quarterly Recap: Is enGene Holdings Inc benefiting from interest rate changesQuarterly Portfolio Report & High Return Stock Watch Alerts - baoquankhu1.vn
enGene (NASDAQ:ENGN) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Does enGene Holdings Inc outperform in volatile markets2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Growth Report: Is enGene Holdings Inc Equity Warrant impacted by rising ratesTrade Risk Assessment & Real-Time Stock Entry Alerts - baoquankhu1.vn
Stock Market Recap: What analysts say about ACON stockTrade Performance Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
enGene Holdings Closes $130 Million Public Offering - MSN
How resilient is enGene Holdings Inc. Equity Warrant stock in market downturnsJuly 2025 Reactions & Weekly High Potential Alerts - Улправда
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Short Covering: Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunity2025 Growth vs Value & Community Trade Idea Sharing - Улправда
Aug Highlights: Can enGene Holdings Inc Equity Warrant stock sustain free cash flow growth2025 Pullback Review & Consistent Income Trade Recommendations - Bộ Nội Vụ
Can enGene Holdings Inc. stock double in next 5 yearsNew Guidance & Safe Entry Momentum Stock Tips - Улправда
How enGene Holdings Inc. stock performs in high volatility markets2025 Price Targets & Weekly High Potential Stock Alerts - ulpravda.ru
How geopolitical tensions affect enGene Holdings Inc. Equity Warrant stockQuarterly Market Summary & High Yield Stock Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a dividend growth opportunityTrade Performance Summary & Growth-Oriented Investment Plans - Улправда
Will enGene Holdings Inc. stock benefit from AI adoption2025 Price Momentum & Daily Stock Trend Watchlist - ulpravda.ru
Is enGene Holdings Inc. stock safe for conservative investorsJuly 2025 Gainers & Reliable Price Action Trade Plans - Улправда
Is enGene Holdings Inc. stock a contrarian buy2025 Retail Activity & Consistent Income Trade Recommendations - Улправда
Operating cash flow per share of enGene Holdings Inc. Warranton enGene Holdings – NASDAQ:ENGNW - TradingView — Track All Markets
enGene (NASDAQ:ENGN) Stock Price Up 7%Still a Buy? - MarketBeat
enGene Holdings Inc Stock Analysis and ForecastValue Traps to Avoid & Hidden Gems with Outstanding Profit Margins - earlytimes.in
Citizens reiterates Market Outperform rating on Engene stock with $21 target - Investing.com Nigeria
Citizens reiterates Market Outperform rating on Engene stock with $21 target By Investing.com - Investing.com South Africa
Piper Sandler Initiates Coverage of enGene Holdings (ENGN) with Overweight Recommendation - MSN
enGene (NASDAQ:ENGN) Shares Gap Up – Should You Buy? - Defense World
enGene (NASDAQ:ENGN) Shares Gap UpStill a Buy? - MarketBeat
enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN) - Seeking Alpha
ETFs Investing in enGene Holdings Inc. Stocks - TradingView — Track All Markets
While Institutions Invested in EnGene Holdings Inc. (NASDAQ:ENGN) Benefited From Last Week's 21% Gain, Private Equity Firms Stood to Gain the Most - 富途牛牛
Analysts Offer Insights on Healthcare Companies: enGene Holdings (ENGN) and Agios Pharma (AGIO) - The Globe and Mail
HC Wainwright Forecasts enGene's Q1 Earnings (NASDAQ:ENGN) - MarketBeat
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages By Investing.com - Investing.com South Africa
enGene (NASDAQ:ENGN) Trading Up 4.6%What's Next? - MarketBeat
Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages - Investing.com Nigeria
enGene Reports Full Year 2025 Financial Results and Provides Business Update - BioSpace
enGene completes enrollment in bladder cancer treatment trial By Investing.com - Investing.com Australia
EnGene Fiscal 2025 Loss Widens - marketscreener.com
enGene (NASDAQ:ENGN) Announces Earnings Results - MarketBeat
enGene completes enrollment in bladder cancer treatment trial - Investing.com
enGene Holdings Inc. SEC 10-K Report - TradingView — Track All Markets
EnGene Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2025 - marketscreener.com
BPASenGene Reports Full Year 2025 Financial Results and Provides Business Update - FinancialContent
enGene announces proposed public offering - MSN
Will enGene Holdings Inc. stock rally after Fed decisionsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Is enGene Holdings Inc. Equity Warrant stock a top pick in earnings season2025 Volume Leaders & Verified Swing Trading Watchlists - Улправда
Weekly Recap: Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Catalysts & Expert Curated Trade Setups - Улправда
Valuation Update: Can enGene Holdings Inc. Equity Warrant stock attract ESG capital inflowsJuly 2025 Closing Moves & AI Powered Buy and Sell Recommendations - Улправда
Is enGene Holdings Inc. Equity Warrant stock a good choice for value investorsWeekly Profit Recap & Fast Moving Trade Plans - Улправда
How enGene Holdings Inc. stock performs in stagflationJuly 2025 Decliners & AI Driven Price Forecasts - Улправда
Engene Holdings Inc (ENGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):